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Abstract
An attempt is made, herein, to reconcile, and integrate, various phenomena associated with magnesium deficiency (MgD) 
in cardiovascular health, disease, and aging as well as reasons for the high incidence of  sudden cardiac death in infants and 
young adults. With new experiments, we demonstrate, for the first time, that very low concentrations of  platelet-activating 
factor (PAF), when added to primary cultured cerebral, neonatal coronary, and aortic vascular smooth muscle (VSM) cells 
(from three different mammals) promote rapid rises in free intracellular Ca2+ ions and a significant, concomitant reduction 
in free intracellular Mg2+ ions; these actions of  PAF being curtailed with a specific membrane-receptor inhibitor of  PAF. 
Our new experiments also demonstrate that addition of  PAF to the VSM cells result in activation of  NF-kB, activation 
of  the proto-oncogenes c-fos and c-jun, a generation/release of  ceramide, and synthesis of  DNA; most of  these actions 
being inhibited by a specific membrane-receptor antagonist of  PAF. In addition, we show, for the first time, formation 
of  4-hydroxy-2-nonenal (4-HNE) in VSM cells incubated in Mg-deficient (MgD) environments or after addition of  PAF. 
This is important because 4-HNE is a well-known inducer of  hydrogen peroxide, known to be formed in MgD VSM cells 
and that 4-HNE is known to induce DNA damage and fragmentation, events that we have shown previously in VSM and 
cardiac muscle cells exposed to low Mg environments. Lastly, our experiments demonstrate that incubation of  cerebral, 
neonatal coronary and aortic VSM cells in low Mg2+ induces: 1. rapid formation of  PAF which can be attenuated greatly 
with a specific membrane-receptor antagonist of  PAF; and 2. rises in cellular levels of  ceramide, NF-kB activation and for-
mation of  the proto-oncogenes, and synthesis of  DNA, all of  which could be inhibited with a specific membrane-receptor 
antagonist of  PAF. These new findings suggest major roles for PAF (and probably PAF-like lipids) and ceramide formation 
in the cardiovascular manifestations of  MgD, inflammation, atherogenesis, aging, and sudden cardiac death in children. The 
significance of  our new findings are reviewed in light of  other works on MgD, inflammation, atherogenesis, sudden cardiac 
death, and aging.
Keywords: Platelet-Activating Factor; Neutral-Sphingomyelinase; Acid Sphingomyelinase; PAF-Like Lipids; C-fos; C-jun, 
8-Hydroxydeoxyguanosine; 4-Hydroxy-2-Nonenal (4-HNE).
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Introduction
A number of  physiologic, nutritional, and biochemical 
homeostatic control mechanisms are responsible for normal 
functions of  the peripheral, coronary and cerebral vasculatures. 
These homeostatic factors maintain both the patency and the 
fluid of  the blood and its elements contained in them. Pathologic 
changes in the peripheral, coronary and cerebral vasculatures 
can result in alterations in vascular wall geometry, arterial and 
endothelial surfaces and in disturbances in oxygenation and 
nutritional status of  blood vessels and the tissues they perfuse. 
Although many theories and hypotheses have been generated to 
account for hypertrophy and stiffening of  resistance vessels in the 
etiology of  hypertension, there is no agreement as to the precise 
mechanisms [for reviews, see [1, 2]].
Approximately 35 years ago, our laboratory suggested that 
a progressive, dietary and/or a metabolic-induced loss of  
magnesium [Mg] from the body beginning early in life, particularly 
in and around the coronary arteries, could lead to coronary arterial 
spasm, ischemic heart disease, and sudden cardiac death [3]. Ever 
since this work was published, a number of  clinical studies have 
been done and published which support this hypothesis, at least in 
adults [4-11]. However, little or no studies have been published to 
either confirm or deny this hypothesis in either infants or young 
adults. Autopsies of  children, who have died as a consequence 
of  accidents, have demonstrated early signs of  atherogenesis 
(i.e., fatty streaks on the walls of  the aorta and carotid arteries in 
young children as early as six years of  age) [12]. It should be noted 
that atherosclerosis is the number-one cause of  premature death 
in developing countries, including the United States and plays a 
major role in etiology of  hypertension and strokes.
Disturbances in diet are known to produce inflammatory 
lesions, promote lipid deposition and accelerated growth and 
transformation of  the smooth muscle cells in the vascular walls 
[for reviews, see [13-18]]. Reduction in dietary magnesium intake 
has been demonstrated, experimentally, to result in hypertension 
[4, 5, 17-20], atherogenesis [16, 21-27], and stroke [15, 27-
34]. Hypermagnesemic diets have been shown to ameliorate 
hypertension, atherogenesis, stroke and certain inflammatory 
responses [14-18, 20-22, 24, 25, 28, 29, 31, 34-41]. In the Western 
World, dietary intake of  magnesium is subnormal, with shortfalls 
of  between 65 and 275 mg of  Mg/d, depending on geographic 
region [14, 42, 43]. Newly compiled USA HHANES data indicate 
that approximately 65 % of  the American population is Mg 
deficient [44]. Several epidemiologic studies in North America 
and Europe have shown that children and adults consuming 
Western-type diets are low in Mg content as are pregnant women 
(i.e., < 30-50 % of  the RDA for these populations) [15, 43-47].
Using sensitive, specific Mg2+- ion selective electrodes, it has been 
shown that patients with hypertension, ischemic heart disease, and 
stroke exhibit significant depletion of  serum and cellular ionized 
Mg2+, the physiologically active Mg [15, 25, 29-31, 35, 57, 71]. 
Such low levels of  ionized Mg2+, when mimicked in vitro, result in 
spasms of  peripheral, coronary, placental, neonatal, and cerebral 
vascular smooth muscle cells, as well as increasing vascular 
reactivity to numerous neurogenic and humoral molecules [3-5, 
15, 19, 25-31, 45-58, 72]. Dietary deficiency of  Mg in rats has 
been shown to not only cause hypertension, but to also cause 
vascular remodeling (i.e., arteriolar wall hypertrophy of  unknown 
origin), rarefaction of  capillaries (known in itself  to result in 
hypertension), as well as release of  cytokines and chemokines 
(involved in inflammatory and atherogenic responses) [23, 74-82]. 
The nuclear factor-kappa B (NF-kB) and the proto-oncogenes (e.g., 
c-fos, c-jun) are two major regulators of  growth, differentiation, 
cell migration, and cell death (e.g., apoptosis) [for reviews, see [83-
86]]. NF-kB is a transcription factor and a pleiotropic regulator of  
numerous genes involved in inflammatory responses, hypertension 
and atherogenesis [for reviews, see [83-85, 87]]. Both NF-kB and 
the proto-oncogenes are thought to be important in numerous 
vascular disease processes such as inflammation, atherogenesis, 
hypertension, and stroke-like events [for reviews, see [83-87]]. 
It is, however, not clear as to what initiates expression of  these 
molecular and cellular events, particularly with respect to how 
Mg deficiency impacts on these vascular events and how low Mg 
causes hypertension, intense vasospasm, inflammation, stroke-
like events, cardiac failure, and sudden cardiac death. Experiments 
performed in-vitro and in-vivo have demonstrated that short-term 
magnesium deficiency (MgD) results in formation/activation of  
NF-kB and the proto-oncogenes in cardiovascular tissues and 
VSM cells [15, 25, 26, 29, 81, 82, 88].
Recently, we have provided experimental evidence for a role for 
sphingolipids, and particularly generation/release of  ceramide, in 
initiating the sequelae of  vascular events brought about via Mg 
deficiency [15, 25, 81, 89-99]. We have found, in cardiovascular 
tissues and diverse cell types, that both Mg deficient diets and 
in-vitro low extracellular Mg ions upregulate all three major, 
enzymatic biochemical pathways causing increased levels of  
cellular ceramide, i.e., upregulation of  serine palmitoyl transferase 
1 and 2, sphingomyelinases (N-, acid-, and alkaline- SMases), and 
ceramide synthase [15, 81, 82, 90, 93-95, 97, 98]. More recently, 
we have identified the existence of  a fourth pathway for synthesis 
of  ceramide in diverse cardiac and VSM cells, namely, "the salvage 
pathway" discovered by Merrill and co-workers in other cell 
types [98]. In these studies, we also demonstrated that activation 
of  protein kinase C isozymes play major roles in generation of  
ceramides [98]. We found these sphingolipid pathways play a 
major role in Mg-deficient upregulation of  proto-oncogene (c-fos, 
c-jun) expression, NF-kB expression as well as DNA synthesis, 
protein kinase C families of  enzymes, cytokines, and telomerase 
activity in diverse cardiac and vascular smooth muscle (VSM) cells 
[15, 81, 82, 89-91, 93, 95, 97-99]. 
Telomeres are critical in regulating genome integrity and hence 
chromosomal integrity [100, 101]. Telomeric DNA characteristics 
are highly conserved molecules among all eukaryotes [100, 101]. 
The telomeres are found at the ends of  the chromosomes, 
consisting of  short nucleotide repeats and specialized proteins, 
which are regulated by telomerases [100, 101]. Chromosomes 
devoid of  telomeres or low telomerase activities undergo 
apoptosis [102-104]. Thus, cells with normal telomerase activities 
are thought to survive periods of  oxidative stress (e.g., production 
of  reactive oxygen and nitrogen species) and curtail apoptosis and 
the aging process [100-104]. Since MgD states have recently been 
shown, both in vivo and in vitro, to promote apoptosis and oxidative 
stress (i.e., DNA damage and production of  reactive oxygen and 
nitrogen species) as well as downregulation of  telomerase activities, 
in diverse cardiovascular tissues and VSM cells, we hypothesized 
that prolonged MgD would lead to premature aging [99]. During 
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these Mg deficient experiments, we noted a fairly rapid synthesis 
of  platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-
3-phosphocholine) [unpublished findings]. In 1997, using primary 
culture of  rat aortic and canine cerebral VSM cells and proton 
nuclear magnetic resonance spectroscopy, we saw peaks in the 
spectra that suggested that Mg - deficient environments led to 
rapid PAF and PAF-like molecules [89].
PAF is manufactured from a specific subclass of  
phosphatidylcholines which contain an ether, instead of  an 
ester, bond at the sn-1 position of  the glycerol backbone. This 
phospholipid precursor is a minor part of  low density lipoprotein 
(LDL), which we and others have found to be elevated in blood 
and tissues of  magnesium deficient animals [91, 105-108]. LDL 
is a major component in a few blood cells, such as leukocytes, 
and along with ox-LDL, is a major pro-atherogenic substance 
[109, 110]. A polyunsaturated fatty acid like arachidonate is 
found in the sn-2 position in the subclass of  phosphatidylcholine 
molecules, and hydrolysis of  this precursor phospholipid forms 
arachidonate for eicosanoid syntheses [110]. Acetylation of  the 
other reaction product, viz., alkyl lysophosphatidylcholine, with 
acetyl-CoA finalizes the synthesis of  PAF, both enzymes being 
tightly regulated [110]. It is important to note that because the 
precursors of  PAF contain polyunsaturated fatty acids, they are 
very susceptible to oxidative attack, often resulting in a number 
of  structural products that resemble PAF (i.e., PAF-like lipids) 
[110]. Interestingly, approximately 20 years ago we reported, using 
proton-NMR spectroscopy and primary cell culture of  diverse 
VSM cells, that lowering [Mg2+ ]0 in the culture media resulted in 
changes in phosphatidylcholine levels and production of  several 
PAF-like molecules [89], most of  which can activate the PAF 
receptors by a G1-coupled mechanism [110-114].
Since PAF is now thought to be an important, maybe critical, 
molecule in etiology of  atherosclerosis and several inflammatory 
conditions and diseases (i.e., allergies, asthma, sepsis, acute 
pancreatitis, diverse bowel disorders, pulmonary diseases, 
diabetes, trauma, and shock among others) [110-115], we designed 
experiments with primary cell cultures of  adult rat aortic, piglet 
coronary arterial, and adult canine cerebral VSM cells to determine 
what role(s), if  any, PAF might play in the generation/release of  
the previously observed increased generation/release of  cellular 
ceramide, proto-oncogene activation, activation of  NF-kB, and 
DNA synthesis and oxidation. Since reactive oxygen species 
(which are formed in MgD environments) can directly cause 
covalent modifications in DNA [115-119], we also investigated 
whether low [Mg2+]0 result in activation of  stress-signaling 
pathways by examination of  production of  4-hydroxy-2-nonenal 
(HNE). HNE, a major aldehyde product of  lipid peroxidation 
in membranes, is known to exert numerous cytotoxic, genotoxic, 
biological, and signaling actions [116-119]. As little as 1.0 uM 
of  HNE can produce chromosomal abnormalities and result 
in DNA fragmentation. We, thus, hypothesized that both PAF 
and low [Mg2+]0 would result in production of  HNE in cultured 
cerebral, aortic and neonatal coronary arterial VSM cells.
Since previous data indicates that low Mg environments can, 
paradoxically, both induce synthesis of  DNA and promote DNA 
damage in primary cultured aortic and cerebral VSM cells [26, 
91, 99], an attempt is made to reconcile, and integrate, these 
phenomena with PAF activation in atherogenesis, inflammation 
and aging in order to possibly explain many of  the cardiovascular 
effects of  MgD.
We demonstrate, herein, for the first time, that very low 
concentrations of  PAF when added to primary cultured 
cerebral, neonatal coronary and aortic VSM cells (from three 
different mammals) promote rapid rises in free intracellular Ca2+ 
ions ([Ca2+] i) and a significant, concomitant reduction in free 
intracellular Mg2+ ions ([Mg2+]i); these actions of  PAF being 
curtailed with a specific membrane-receptor inhibitor of  PAF. 
Our new experiments also demonstrate that addition of  PAF 
to the VSM cells result in activation of  NF-kB, activation of  
the proto-oncogenes c-fos and c-jun, a generation/release of  
ceramide, and synthesis of  DNA; most of  these actions being 
inhibited by a specific membrane-receptor antagonist of  PAF. In 
addition, we demonstrate, for the first time, formation of  HNE 
in VSM cells incubated in MgD environments. This finding is 
important because HNE is a well-known inducer of  hydrogen 
peroxide, formed in MgD VSM cells [[15, 88] unpublished 
findings], and that HNE is known to induce DNA damage and 
fragmentation, events that we have shown are also found in 
VSM and cardiac muscle cells exposed to low Mg environments. 
Lastly, our experiments show that incubation of  the cerebral, 
neonatal coronary and aortic VSM cells in low [Mg2+]0 induce: 1. 
rapid formation of  PAF which can be attenuated greatly with an 
inhibitor of  PAF; and 2. rises in cellular levels of  ceramide, NF-kB 
activation and formation of  the proto-oncogenes, and synthesis 
of  DNA, all of  which could be inhibited greatly with a specific 
membrane-receptor antagonist of  PAF. These new findings 
suggest major roles for PAF (and probably PAF-like lipids) and 
ceramide formation in the cardiovascular manifestations of  MgD, 
inflammation, atherogenesis, aging and sudden cardiac death 
in children. The significance of  our new findings are reviewed 
in light of  other works on MgD, inflammation, atherogenesis, 
sudden cardiac death and aging.
Materials and Methods
Animals, tissue preparation and incubation
Adult male rats (16 to 20 weeks old, 275-325 g) were killed 
by decapitation and exsanguinated as previously [26, 30, 51]. 
All experiments were approved by The Animal Use and Care 
Committee of  the State University of  New York Downstate 
Medical Center. Thoracic aortae were excised, immediately placed 
in normal Krebs-Ringer bicarbonate (NKRB) solution at room 
temperature, cleaned of  blood, loose connective tissue, and fat, 
and the aortae cut into rings about 2 to 3 mm long, as described 
previously [26, 30, 51]. Endothelial cells were rubbed off  with 
wet filter paper to get only pure, viable VSM cells [51, 81, 82, 
85]. Concentrations of  ionized Mg2+ and Ca2+ in culture media 
were determined precisely using ion-selective electrodes (NOVA 
Biomedical Corp., Waltham, MA) [57].
Mongrel dogs (15+/- 3 kg) were anesthetized with intravenous 
sodium pentobarbital (40 mg/kg) and sacrificed by bleeding 
from the common femoral arteries [30]. After craniotomy, the 
brains were rapidly removed, placed in normal NKRB solution 
at room temperature, and basilar and middle cerebral arteries 
excised, cleaned of  arachnoid membranes and blood elements, 
and the vessels were denuded of  endothelium as described 
previously [30, 48]. The vessels were cut into segments about 3 
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to 4 mm in length [48].
Four-five piglets (7-10 days old) were anesthetized with saffan ( 
12 mg/kg i.m.; Glaxo or Pittman Moore Cos.). The hearts were 
removed and coronary arteries were extracted and denuded of  
endothelium, as previously [120], prior to enzymatic digestion. 
By use of  monoclonal antibodies for alpha-actin and trypan blue 
exclusion, we found that 96-98% of  the VSM cells were pure 
smooth muscle cells [120]. The pure VSM cells were cultured as 
described previously, in Dulbecco's modified Eagle's media, in a 
humidified atmosphere composed of  95% air-5% CO2 [120]. The 
cells were exposed to media containing either 0.15, 0.30, 0.48, 0.6, 
or 1.2 mM [Mg2+]0 for periods of  from 15 min to 18-24 hr prior 
to manipulations.
Primary culture of  aortic and cerebral VSM cells
Rat aortic and canine cerebral VSM cells were isolated according 
to established methods in our labs and cultured in Dulbecco’s 
modified Eagle’s medium containing 1.2 mmol/l [Mg2+]0, fetal calf  
serum (FCS) and antibiotics at 37°C in a humidified atmosphere 
composed of  95% air-5% CO2 [26, 30, 51]. After confluence was 
reached, the VSM cells were placed in media containing either 
0.15, 0.30, 0.6, 1.2, or 4.8 mmol/l [Mg2+]0 for varying periods of  
time (15 to 120 min or 18 to 20 hr) .
[Ca2+]I measurements
Intracellular free cytosolic Ca2+ ([Ca2+]i) was measured with digital 
image analysis and fura-2/AM as detailed previously [26, 30, 51, 
55]. Primary smooth muscle cells obtained from rats, dogs and 
piglets (as in above) were seeded on glass cover slips (12 mm in 
diam; about 1x106 cells per cover slip) and used 2 to 3 days after 
seeding as described previously [26, 30, 51, 55]. After exposing the 
cells to either vehicle (NKRB) with and without PAF or NKRB 
with varying [Mg2+]0 with and without PAF, monolayers of  VSM 
cells, grown on the coverslips, were loaded with 2.0 umol/l fura-2 
AM and 0.12% pluronic acid F-127 (60 min, 37°C) [26, 30, 51, 
55]. In some experiments, we added the PAF inhibitor, WEB2086 
(5uM, Sigma Biochemicals, St. Louis, MO), scyphostatin (75 
uM; N-SMAse inhibitor), or desipramine (20 uM; acid-SMAse 
inhibitor) to the incubation media. The experimental procedures 
for [Ca2+]I measurements were carried out as described previously 
with the use of  fura-2 AM [26, 30, 51, 55]. The [Ca2+]I was 
calculated according to the following equation:
[Ca2+]I = Kd x B x (R-Rmin)/(Rmax –R)
A Kd of  224 nmol/l was used for the fura-2/Ca
2+: fura-2 complex 
excited at 380 nm.
[Mg2+]I measurements
Intracellular free cytosolic Mg2+ ([Mg2+]i) was measured with 
digital image analysis and mag fura-2/AM as detailed previously 
[28, 121]. To obtain absolute values of  [Mg2+] in single VSM 
cells, a final concentration of  5 uM mag-fura-2 pentapotassium 
salt containing either 10 mM (max) or 0-mM MgSO4 (min) was 
used for an in vitro calibration. In some experiments, we added 
WEB2086 or the SMAse inhibitors, as above. The calibration 
solutions also contained (in mM): KCl 115, NaCl 20, and HEPES 
5, buffered with NaOH to pH 7.1 under air, at 37°C. From these 
standard solutions, the maximium and minimum intensities of  
flourescence were obtained at the 335 and 370 nm wavelengths 
and the ratio of  R335/370 was generated. [Mg
2+]i was calculated 
according to the following equation:
[Mg2+]i = Kd x B x (R-Rmin)/ (Rmax-R),
and a Kd of  1.5 mM was used for the mag-fura-2/Mg
2+ complex 
[28, 121]. B is the ratio of  fluorescence intensity of  free mag 
-fura-2 to Mg-bound mag-fura-2 at 370 nm.
Expression of  NF-kB
The VSM cells were incubated for 18 to 24 hr in either vehicle 
(NKRB) with and without PAF or modified NKRB containing 
various [Mg2+]0 with and without PAF, harvested, and assayed for 
the p65 subunit of  NF-kB [81, 82, 88, 97]. In some experiments, 
we added the PAF inhibitor, WEB2086 (5uM) to the incubation 
media. The NF-kB p65 (A) rabbit polyclonal IgG immunoaffinity 
column, purchased from Santa Cruz Biotechnology (Santa Cruz, 
CA) was used to concentrate the transcription factor [81, 82, 88, 
97]. After elution, gel electrophoresis, transfer to a nitrocellulose 
membrane, and Western blotting, the p65 subunit was assayed 
using the same IgG for immunodetection [81, 82, 88, 97].
Induction and measurement of  c-fos and c-jun
Primary cultures of  rat aortic, piglet coronary and canine cerebral 
VSM cells were incubated with either vehicle (NKRB) with 
and without PAF or modified NKRB containing the various 
concentrations of  [Mg2+]0 with or without PAF for the varying 
intervals of  time. In some experiments, we added the PAF 
inhibitor, WEB2086 (5 uM) to the incubation media. Cells were 
then lysed, and total cellular RNA extracted using the lithium-
urea method [26, 97]. Northern blot analyses were performed as 
described previously [26, 97]. Blots were hybridized to a randomly, 
primed specific cDNA probe for c-fos or c-jun and then exposed 
to Kodak Y-Omat film (Rochester, NY) for 2 to 5 days at -70°C 
[26, 97]. Relative amounts of  c-fos and c-jun expression were 
determined with a densitometric scanner as previously [26, 97].
Measurement of  cellular levels of  ceramide 
Cellular levels of  pulsed-labeled ceramide were measured utilizing 
methods we have published previously [81, 82]. Briefly, the VSM 
cells, in primary cultures, were exposed to vehicle (with or without 
PAF) or to low [Mg2+]0 (with or without PAF) and [
3H] palmitic 
acid (4-20 uCi/ml) at 37°C, rinsed with fresh NKRB solution 
or low-Mg NKRB solution and transferred to their respective 
NKRB’s (under 95% oxygen-5% CO2) for 3 hr. The cells were 
washed for 5-10 min with unlabeled media, transferred to culture 
media containing either 0.3 or 1.2 mmol/l [Mg2+]0 and either 
vehicle (NKRB) or the PAF inhibitor, WEB2086 (5 uM). Lipid 
extractions were performed for phospholipid analysis using 
techniques similar to those we have reported previously [81, 82, 
89, 90]. Total ceramide cellular levels were determined similar to 
methods we have used recently employing conversion of  ceramide 
into ceramide-1[32P] phosphate by Escherichica coli DAG kinase 
followed by lipid separation on high-performance TLC plates [81, 
82]. After autoradiography, spots corresponding to ceramide-1-
phosphate were carefully scraped into vials, and the radioactivity 
counted in a scintillation counter (LS-6500; Beckman, CA). 
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Quantitation of  ceramide levels and results as picomoles per 106 
cells were determined. The results were expressed as umol/ug 
protein using a Bradford reagent for total protein (Bio0Rad Labs, 
Hercules, CA) following the manufacturer’s protocol using a 96-
well plate [81, 82].
DNA synthesis
DNA synthesis was examined by incorporation of  the thymidine 
analog bromodeoxyuridine (BrdU) into VSM cells [26]. 
Subconfluent cells, on 12-mm coverslips, that became quiescent 
after transfer to serum-free media (DMEM + 0.1% bovine serum 
albumin [BSA] for 24 hr were reincubated with DMEM + 10% 
FCS in various concentrations of  [Mg2+]0 ( i.e., 1.2, 0.6, 0.48, and 
0.3) with or without PAF (with or without 5 uM WEB2086) for 
24 hr. At the end of  the low Mg2+ with or without PAF (and 
WEB2086) or the SMAse inhibitors, BrdU (15 umol/l) was added, 
and the cells were visualized using a BrdU monoclonal antibody 
(Zymed; San Francisco, CA) followed by the ABC method [26]. 
The BrdU-positive cell nuclei were counted in four to six high-
power fields and related to the total cell number/ high-power field 
[26].
Measurement of  PAF
The methodology outlined by Travers et al [122] and Alapart [123], 
employing gas chromatography-mass spectrometry (with some 
modifications for our VSM cells), was utilized to measure PAF. 
Lipids were isolated and subjected to GC-mass spectrometry. All 
measurements were made in triplicate.
Measurement of  8-hydroxydeoxyguanosine (8-OH-dg)
Measurement of  8-OH-dg is thought by many experts to be a 
good method for assessing DNA damage in a variety of  cell types 
[124-126]. Use of  liquid chromatography-mass spectrometry is 
considered the method of  choice by most experts [124-126], and 
is the method employed in our studies [125].
Measurement of  protein-bound 4-HNE (4-hydroxy-2-
nonenal)
For these measurements, we followed the methodology outlined 
by Hill et al for cultured VSM cells [127]. As they indicated, we 
utilized radiolabeled 4-HNE (i.e., [3H] 4-HNE, 50 uM, 2.7-3.0 x 
106 cpm per well) was added in the presence of  low Mg with 
or without WEB2086. Radioactivity (in the supernatants) was 
utilized for HPLC analysis. Protein-bound 4-HNE was measured 
by scintillation counting and normalized as per Hill et al [127].
Chemicals and drugs
Fura-2/AM, mag-fura-2/AM, FCS, pluronic F-127, platelet 
activating factor (PAF), WEB2086, desipramine, scyphostatin, 
nifedipine, and streptomycin were purchased from Sigma Aldrich 
Chemical Company (St.Louis, MO). All chemicals used to make up 
NKRB or modified NKRB solutions were of  the highest grades 
available and purchased from Fisher Scientific Co. (Springfield, 
NJ).
Statistics
Where appropriate, results were expressed as means +/- SEM and 
were examined for statistical significance by means of  Student’s 
t-tests and analysis of  variance (ANOVA) using Scheffe’s contrast 
test. Values of  P < 0.05 were considered to be statistically 
significant.
Results
Influence of  [Mg2+]0 on [Ca2+]i: effects of  WEB2086
Table 1 indicates that reduction in [Mg2+]0 results in a rapid, 
concentration-dependent increase in free [Ca2+]I in rat aortic, 
piglet coronary and cerebral VSM cells, which plateaus within 2-5 
min, similar to that reported previously [26, 28, 30, 51, 55, 56, 72, 
96]. Although not shown, these elevations in free, ionized cellular 
Ca2+ were maintained for at least 8-12 hr. The data presented in 
Table 1 also indicate that when all of  the extracellular Ca2+ in 
the NKRB solution is removed, the basal levels of  [Ca2+]I are 
lowered dramatically 92-98 %, similar to that reported previously. 
Prior incubation of  the VSM cells (30-60 min) with the calcium 
channel blocker, nifedipine (10-6 M), reduced the low [Mg2+]0 –
induced rises in [Ca2+]I by 80-85 % (Table 1). Interestingly, prior 
incubation of  the VSM cells with WEB2086 reduced the low 
[Mg2+ ]0 -induced rises in [Ca
2+]i by 55-65% (Table 2).
Influence of  PAF on [Ca2+]I and [Mg2+]i
Addition of  PAF (1-1,000 nM) to the primary cultured VSM cells 
resulted in a rapid, concentration-dependent rise in intracellular 
free Ca2+. These elevations induced by PAF were initiated at 
Table 1. Influence of  [Mg2+]0  on free intracellular Ca2+ in rat aortic, piglet coronary and cerebral vascular smooth muscle 
cells in primary culture.
 [Ca2+]i, nM
  [Mg2+]0     Rat Aortic VSM    Piglet Coronary VSM Canine Cerebral VSM
Controls    93.8+/-3.8           106.2+/-0.76           98.6 +/- 4.2
0.6 148.6+/- 12.8*     132.6+/- 2.8*            66.8+/- 1.8*
0.3  178.8+/- 12.4*    158.4+/- 3.3*            228.2+/- 3.3*
0  625+/-32.4*         475.6+/-12.6*             686.6+/- 18.6*
0,0-Ca        2.82+/- 0.22*        6.64+/-0.32*             1.28+/-0.16*
0+ NF      114.8+/-4.6         126.4+/-2.2              115.8+/- 4.8
Values are means +/- S.E.M.
Results were obtained at 2-5 min after incubation in the different [Mg2+]0(mM) and [Ca
2+]0 . *P<0.001, ANOVA.
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~45-60 sec after contact with the VSM cells and peaked at about 
2-10 min rising 4-20-fold over normal, depending on time and 
concentration (Table 3). If  we pre-incubated the VSM cells with 
WEB2086, most of  the PAF-induced elevations in Ca2+ were 
completely inhibited (Table 3), indicating that the changes in 
[Ca2+]i were brought about by PAF acting on their specific VSM 
cell membrane-receptors.
Turning to actions of  PAF on intracellular Mg2+, we found 
that addition of  PAF (10-1,000 nM) to the aortic and cerebral 
VSM cells significantly lowered the [Mg2+]I 10-22 %, depending 
on concentration, peaking within 3-20 min depending on PAF 
concentration (Table 4). Concomitant with these changes 
in cellular free Mg2+, we noted rises in [Ca2+]I (Table 3). The 
reductions in [Mg2+]i were somewhat curtailed when the cells were 
pretreated with WEB2086 (Table 4). Although not shown, similar 
results were noted in the piglet coronary arterial VSM cells.
Low [Mg2+]0 and PAF result in early expression of  proto-
oncogenes: effect of  WEB2086
Previously, we have demonstrated that exposure of  VSM cells to 
low [Mg2+]0 or feeding animals low dietary Mg intake result in 
increased levels of  both c-fos and c-jun [26, 97]. The VSM cells 
showed upregulation of  the proto-oncogenes within 30-120 min 
after reduction in [Mg2+]0 [26, 97]. Addition of  PAF (1-1000 nM) 
to either aortic, piglet, or cerebral VSM cells in NKRB solution 
also induced formation of  both c-fos and c-jun (Figure. 1).
Interestingly, if  we preincubated the VSM cells, exposed to low 
Mg2+, with the PAF inhibitor (WEB2086), the induction of  the 
proto-oncogenes was attenuated dramatically (see Figure 2), while 
the induction of  both c-fos and c-jun observed after incubation 
with PAF (incubated in WEB2086 - NKRB) was almost 
completely inhibited (Figure 3).
Exposure of  primary cultured VSM cells to low [Mg2+]0 or 
PAF results in NF-kB p65 expression: influence of  PAF 
inhibitor
Table 5 indicates that the p65 element of  NF-kB is increased after 
incubation in either low [Mg2+]0 or PAF. Pre-incubation of  the 
VSM cells with WEB2086 drastically reduced the expression of  
p65 on addition of  either low [Mg2+]0 or PAF.
Exposure of  primary cultured VSM cells to low 
[Mg2+]0 or PAF results in increased DNA synthesis and 
8-hydroxydeoxyguanosine (8-OH-dg)
The results presented in Tables 6 and 7 suggest that exposure 
of  cerebral and aortic VSM cells to either low [Mg2+]0 or PAF 
appears to induce a concentration-dependent increase in DNA 
synthesis whereas exposure to either low [Mg2+]0 or PAF results, 
paradoxically, in 6-10 fold increased formation of  8-OH-dg 
suggesting increased oxidation of  the DNA. Incubation of  
the MgD cells with WEB2086 resulted in decreased synthesis 
of  DNA and only 2-3 fold increase in 8-OH-dg. Although not 
shown, similar results were noted for the piglet coronary arterial 
muscle cells.
Exposure of  primary cultured VSM cells to low [Mg2+]0 or 
PAF results in generation/release of  ceramide: influence of  
WEB2086, desipramine and scyphostatin
Incubation of  the VSM cells in low [Mg2+]0 resulted in rises in 
ceramide, similar to that shown previously [81, 82, 89, 90, 95]. 
Likewise, exposure of  the VSM cells to PAF (in NKRB solution) 
also resulted in rises in ceramide, but less than that seen in low 
[Mg2+]0. Preincubation of  the VSM cells in either low [Mg
2+]0 
or NKRB containing the PAF membrane-receptor antagonist 
attenuated the rises in ceramide (Table 8). Preincubation of  the 
VSM cells with desipramine and scyphostatin (but not either 
alone) resulted in almost complete inhibition of  the rises in 
ceramide observed in low [Mg2+]0 and PAF addition (Table 9).
Influence of  PAF and low Mg2+ on 4-HNE levels: Effects of  
WEB2086
The data shown in Table 10 indicate that both PAF and low 
Mg2+ cause profound increased levels of  4-HNE in aortic and 
cerebral VSM cells, whereas the presence of  WEB2086 inhibits 
most of  the elevations in 4-HNE. Although not shown, similar 
observations were noted in neonatal coronary VSM cells.
Discussion
To our knowledge, the results reported, herein, are the first 
demonstration that low concentrations of  PAF in at least three 
different types of  VSM cells (from three different mammals), 
including neonates, results in formation of  ceramide, activation 
of  NF-kB, expression of  two different proto-oncogenes, and 
DNA synthesis coupled to rises in intracellular free Ca2+ and 
significant, albeit small lowering of  intracellular free Mg2+. We also 
demonstrate that these diverse actions of  PAF occur at specific 
VSM cell PAF membrane-receptors. In addition, we demonstrate, 
concomitantly, that PAF can induce oxidation of  DNA, which 
also occurs via distinct PAF membrane-receptors. 
Table 2. Influence of  WEB2086 on elevation in [Ca2+]i induced by low [Mg2+]0 in rat aortic, piglet coronary and canine 
cerebral VSM  in primary culture.
[Ca2+]i, nM
[Mg2+]0 + WEB Rat aortic VSM  Piglet coronary VSM Canine cerebral VSM
Controls     92.6+/- 2.8             102.8+/- 5.8          94.8+/- 3.6
0.3+WEB    128.8+/-4.6*           116.8+/-2.6*          148.2+/-4.4*
Values are means +/- S.E.M. and should be compared to mean values in Table 1.
*P<0.01 compared to controls and paired mean values in Table 1 (ANOVA).  
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Table 3. Influence of  PAF on intracellular free Ca2+ in diverse primary cultured VSM cells with and without WEB2086 added 
to the incubation media.
[Ca2+]i, nM
PAF, nM      Rat aortic VSM   Piglet coronary VSM Canine cerebral VSM
Controls      89.6 +/- 2.6       110.0+/- 4.6                   102.4+/- 3.8
1 272.2+/- 14.8*    376.0+/- 11.6*          422.8+/- 16.4*
10  398.6+/-16.2*    524.8+/- 22*          656.6+/- 24.6*
100 496.8+/-28.2*     674.8+/-26*                   938+/-36.8*
100+WEB  98.8+/- 3.8        102+/-3.4                        112.8+/- 6.4
Values are means +/- S.E. M.
*P<0.001 compared to controls and other paired values (ANOVA).  
Table 4. Addition of  PAF to primary cultured rat aortic and canine cerebral VSM cells significantly reduces intracellular 
[Mg2+].
[Mg2+]i, uM                                                           
PAF, nM           Rat aortic VSM    Canine cerebral VSM
Controls           626+/- 52            732+/-78
10 564+/-42*           647+/-32*
100 531+/-27*           601+/- 25*
1,000 502+/-22*           570+/-21*
100 + WEB    542+/-28**          608+/-26**
Values are means +/- S.E.M.
*P<0.01 compared to controls (ANOVA).
**P<0.05 compared to controls but not significantly different from 100 nM PAF (ANOVA).
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Figure 2. Exposure of  primary cultured aortic, cerebral and piglet coronary VSM cells to WEB 2086 prior to low [Mg2+]0 





















































































































Figure 3. Exposure of  primary cultured aortic, cerebral and piglet coronary VSM cells to WEB 2086 prior to addition of  
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Table 5. Exposure of  primary cultured VSM cells to either low [Mg2+]0 or PAF results in expression of  NF-kB p65: influence 
of  WEB2086.
Expression of  p65, densitometric units
 [Mg2+]0 or PAF, nM     Rat aortic VSM  Canine cerebral VSM
Controls 12+/-2.2     8.6+/- 1.2
0.6 mM [Mg2+]0                  282+/-12*       345+/- 27*
0.3 mM [Mg2+]0            465+/-21*          566+/-36*
0.15 mM [Mg2+]0            606+/-32*       712+/-48*
PAF, 100                  425+/-18*          592+/-38*
0.3 mM Mg2+ + WEB   306+/-14**       376+/-32**
PAF(100) + WEB           252+/-26***      336+/-28***
Values are means +/- S.E.M.
*P<0.01 compared to controls (ANOVA).
**P<0.01 compared to 0.3 mM [Mg2+]0 alone (ANOVA) 
***P<0.01 compared to 100 nM PAF alone (ANOVA).
Table 6. Exposure of  primary cultured VSM cells to either low [Mg2+]0 or PAF results in increased DNA synthesis: influence 
of  WEB2086.
% BrdU Incorporation (% positive nuclei)
[Mg2+]0 or PAF, nM    Aortic VSM     Cerebral VSM  Piglet coronary VSM
Controls                          7.82+/- 1.2     8.4+/-0.8           6.4+/-0.6
0.6 mM Mg2+                  22.4+/-2.8*    28.6+/-3.2*     24.8+/- 1.6*
0.3 mM Mg2+          36.6+/- 4.2*     44.4+/-3.4*       38.6+/- 3.6*
0.15 mM Mg2+        72.6+/- 6.8*     86.8+/- 7.2*    64.6+/- 4.6*
PAF, 100                           42.4+/-3.8**  48.6+/-3.6**   40.2+/-4.2**
0.3 mM Mg + WEB   26.4+/-2.8***  34.2+/-2.8***   28.8+/-1.6***
PAF(100) + WEB       24.6+/- 2.6     26.8+/-3.4          28.6+/-1.8
Values are means +/- S.E.M.
*P<0.01 compared to all other paired values (ANOVA).
**P<0.01 compared to controls (ANOVA).
***P<0.01 compared to mean values with 0.3 mM [Mg2+]0 alone (ANOVA).
Table 7. Exposure of  primary cultured VSM cells to either low [Mg2+]0 or PAF results in increased levels of  8-OH-dG: influ-
ence of  WEB2086.
8-OH-dG, ng
[Mg2+]0 or PAF, nM     Rat aortic VSM   Canine cerebral VSM
Controls                    6.82+/-2.8            4.64+/-1.2
0.3 mM Mg2+                42.4+/-5.6*           55.8+/- 6.6*
0.15 mM Mg2+               68.6+/-6.6*          74.4+/-6.8*
PAF, 100                     58.4+/-4.8*          66.4+/-5.6*
0.15 mM Mg + WEB  12.8+/-1.2**      14.2+/-2.8**
PAF(100) + WEB        15.6+/-2.6***    18.4+/-3.2***
Values are means +/- S.E.M.
*P<0.01 compared to controls.
**P<0.05 compared to controls and significantly different from values with 0.15 mM Mg2+ alone.
***P<0.01 compared to controls and significantly different from values with 100 nM PAF alone.
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Table 8. Exposure of  primary cultured VSM cells to either low [Mg2+]0 or PAF results in generation/release of  ceramide: 
influence of  WEB2096.
 Total ceramide (pmol/108 cells)
[Mg2+]0, mM or PAF, nM      Rat aortic VSM  Canine cerebral VSM
Controls                                            37+/- 4.4               26+/- 2.8
0.3 [Mg2+]0                         82+/- 6.8*         54+/- 4.8*
100 PAF                       66+/- 5.6**         42+/- 3.6**
0.3 [Mg2+]0 + WEB              54+/- 3.6***      36+/- 2.8***
100 PAF + WEB                42+/- 3.4              24+/-1.8
Values are means +/- S.E.M.
*P<0.01 compared to all other paired values (ANOVA).
**P<0.05 compared to all other paired values (ANOVA).
***P<0.01 compared to mean values in 0.3 mM [Mg2+]0 alone (ANOVA).
Table 9. Influence of  an N-SMase (scyphostatin) and an acid SMase (desipramine) inhibitor on rises in ceramide levels 
induced by low Mg2+ and PAF in primary cultured VSM cells.
Ceramide (pmol/108 cells)
[Mg2+]0, mM or PAF, nM      Rat aortic VSM   Canine cerebral VSM
0.3 mM Mg2+ w/scyph         52+/- 4.8*            38+/- 3.1*
0.3 mM Mg2+ w/des           42+/- 3.2*           32+/- 1.8*
0.3 mM Mg2+ w/scyph-des    34+/- 2.8**          24+/- 1.6**
100 PAF w/scyph              55+/- 3.2***       36+/- 1.8***
100 PAF w/des                40+/- 2.8***       31+/- 1.3***
100 PAF w/scyph-des          35+/- 1.5****     25 +/- 1.1****
Values are means +/- S.E.M. and should be compared to mean paired values in Table 8.
*P<0.01 compared to paired values in Table 8 (ANOVA).
**P<0.05 compared to paired values in Table 8 (ANOVA). 
***P<0.05 compared to paired values in Table 8 (ANOVA).
****P<0.01 compared to values without scyph or des (ANOVA). 
Table 10. Influence of  low [Mg2+]0 and PAF on 4-HNE levels in primary cultured VSM cells: effects of  WEB2086.
4-HNE levels, nmol/mg protein 
   [Mg2+]0, mM or PAF, uM      Rat aortic VSM   Canine cerebral VSM
Controls                         0.18+/- 0.04       0.12+/- 0.03
0.3 Mg2+                         3.75+/- 0.42*      2.92+/- 0.22*
0.15 Mg2+                        6.32+/- 0.56*      5.26+/- 0.38*
10 PAF                           3.12+/- 0.28**   2.28+/- 0.20**
100 PAF                          5.84+/- 0.48**    4.24+/- 0.26**
0.15 Mg2+ + WEB                   0.62+/- 0.08*** 0.52+/- 0.06***
100 PAF + WEB                    0.98+/- 0.12**** 0.84+/- 0.08****
Values are means +/- S.E.M.
*Significantly different from controls and other low Mg values (P<0.001, ANOVA).   
** Significantly different from controls and other PAF values (P<0.001, ANOVA). 
***Significantly different from controls and other low Mg values (P<0.001, ANOVA). 
****Significantly different from controls and other PAF values (P<0.001, ANOVA).
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Moreover, we provide new evidence for lipid peroxidation and 
most likely a pathway for formation of  H2O2 in the presence 
of  PAF and low [Mg2+]0. Lastly, we provide evidence for the 
idea that many of  the VSM cell effects of  low [Mg2+]0 may be 
a consequence of  synthesis/release of  PAF and PAF-like lipids 
acting via sphingolipid pathways, particularly ceramides. It is 
important to point out, here, that these are the very first findings 
to implicate low Mg and PAF in regulation (and their existence 
in neonatal coronary VSM cells) of  several ceramide pathways in 
very young mammals, which could have major implications for 
the numerous, unexplained sudden cardiac deaths, around the 
world, in infants and young adults [128-134].
Molecular pathways for synthesis of  ceramides and low Mg
The molecular pathways via which ceramides are synthesized 
are known to be conserved between yeast and mammals [135]. 
The de novo synthesis of  ceramide is brought about via the action 
of  serine palmitoyl-CoA transferase (SPT), 3-ketosphinganine 
reductase, ceramide synthase (CS), dihydroceramide desaturase 
and SM synthase (SMS). This reaction directly affects 
sphingomyelin (SM), phosphatidylcholine (PC) and ceramide as 
well as diacylglycerol (DAG) levels. Three of  us have previously 
noted, using primary cerebral and peripheral VSM cells in 
culture, that a variation in [Mg2+]0 influences the cellular levels 
of  SM, PC, DAG, and ceramide [25, 81, 82, 89, 90, 93-95, 97-
99]. Ceramide, either released as a consequence of  SMase acting 
on SM and/or activation of  either SPT or SMS or activation 
of  CS is now thought to play important roles in fundamental 
pathological processes such as cell proliferation, angiogenesis, cell 
adhesion, diverse immune functions, microcirculatory functions, 
membrane-receptor functions, programmed cell death (i.e., 
apoptosis), atherogenesis, inflammation, and aging [135-141]. 
Over the past two decades, our laboratories have found that low 
Mg2+ (both in vivo and in vitro) is a fundamental regulator of  all 
of  the above major enzymatic pathways and causes upregulation 
of  ceramide in multiple cardiovascular tissues and cells [25, 81, 
82, 89, 90, 93-95, 97-99, 150]. Interestingly, we very recently 
have found evidence for the upregulation of  the unique "salvage 
pathway" for additional synthesis of  ceramide in the presence 
of  low [Mg2+]0 in diverse cardiovascular tissues and cells [82]. 
Although the activation of  N-SMase, acid-SMase, SPT-1, SPT-2 
as well as SMS by low [Mg2+]0 results in (and ensures) ceramide 
production in cardiovascular tissues [25, 81, 82, 89, 90, 93, 94, 97-
99], the activation of  CS (by low [Mg2+]0) via the "salvage pathway" 
could result in additional levels of  de novo ceramide along with 
elevated levels of  sphingosine [82]. Our recent studies provide 
new evidence for the existence of  the latter ("salvage") pathway 
in cardiovascular tissues via activation of  several protein kinase 
C (PKC) isozymes, with PKC -zeta playing a dominant role [82]. 
Previously, we suggested that new therapeutic and prophylactic 
approaches in the management of  some cardiovascular 
diseases (e.g., hypertension, coronary ischemic syndromes, and 
atherosclerosis) could be helped/ameliorated with more insight 
into this Mg-regulated pathway [82]. In view of  the present 
work on PAF, we believe this may be critical in management of  
inflammatory diseases and atherosclerosis as well as the aging 
process, and in prevention of  sudden cardiac death, particularly 
in infants and young adults.
Low Mg, intracellular Ca, PAF, PAF-like lipids and ceramide
Research on PAF and PAF-like lipids has generated considerable 
interest over the past decade [110-115, 143-149, 150]. This research 
has resulted in the acquisition of  a great deal of  knowledge into 
the biology, chemistry, physiology, and pathology of  these unique 
molecules, e.g., PAF synthesis, transport, molecular structures, 
heterogeneity of  PAF receptors, regulation of  gene expression 
by PAF, signal-transducing roles of  PAF and PAF-like lipids (e.g., 
activation of  tyrosine kinases, MAP kinases, and NF-kB), PAF 
functions in circulatory and immune physiology, reproduction, 
tumor growth, and infectious diseases.
PAF receptor (PAF-R) signaling is known to be linked to various 
second messenger networks through phospholipases leading to 
Ca2+ fluxes. We show in the present study that addition of  low 
concentrations of  PAF to primary VSM cells results in rapid rises 
of  intracellular free Ca2+ concomitant with release/synthesis of  
ceramides via N- and acid-SMAses leading to activation of  NF-
kB and proto-oncogenes followed by both synthesis and oxidation 
of  DNA, particularly in the presence of  low [Mg2+]0. Our new 
findings indicate that these PAF actions must perforce occur via 
specific PAF-Rs, as the specific PAF-R membrane antagonist, 
WEB2086, either prevents or ameliorates these VSM actions of  
PAF. Our new results also demonstrate that these actions of  PAF 
appear to be dependent on its ability to elevate intracellular free 
Ca2+ coupled to reduction in intracellular free Mg2+. These new 
latter observations are the first of  their kind, to our knowledge, 
in any cell type.
The present observations demonstrate that ceramide release (via 
activation of  both N- and acid SMAses) probably occurs as a 
potential consequence of  PAF (and/or PAF -like lipids) action 
in VSM cells exposed to low [Mg2+]0. We believe that these 
observations have a direct relationship to facts that low dietary 
Mg levels lead to atherogenesis [21, 22, 25, 29], inflammatory 
conditions [37, 38, 60-62, 67, 74, 76, 77-80], and reduced 
telomerase activities in cardiovascular tissues and cells [99]; the 
latter a potential critical factor in the aging process [10-104]. If  
our present findings, taken together with our previous studies [15, 
25, 26, 81, 82, 89, 90-99, 107, 150], are confirmed they could lead 
to new approaches to therapy and prophylaxis of  cardiovascular 
and inflammatory diseases with specific antagonists of  PAF-R 
and supplements of  diets with Mg, particularly as more than 65 
% of  The North American population is MgD. In addition, this 
combination therapy/prophylaxis could lead to longer life spans 
and better quality of  life processes, and probably less sudden 
cardiac deaths in young adults and infants, provided pregnant 
women and their offspring are adequately supplemented with Mg 
in their diets.
Significance of  low Mg-induced DNA synthesis and DNA 
oxidation: roles of  PAF, oxidized phospholipids, and 
ceramide
We confirm in this report that exposure of  diverse VSM cells to 
low extracellular Mg2+ results in oxidation of  DNA [99]. These 
data, when taken together with other studies [15, 26, 88-90, 95, 
152], support the hypothesis that MgD, unless checked early-on, 
"probably will contribute in a major way to the atherosclerotic and 
aging processes [15, 21, 22, 25, 67, 99, 106, 150, 151]". The fact 
that this event is linked to activation of  several major enzymatic 
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sphingolipid- ceramide pathways and PAF production in primary 
VSM cells provides further evidence for important roles for 
generation of  ceramide and PAF in atherogenesis, inflammation, 
hypertension, and heart failure; all of  these being involved in 
diverse and major ways in the aging process [99, 107, 110-115]. 
More than 10 years ago, working with primary cultured cerebral 
VSM cells we first demonstrated low [Mg2+]0 levels result in rapid, 
increased formation of  molondialdehyde [MDA]. This formation 
of  MDA was also noted in diverse cardiovascular tissues extracted 
from rats subjected to 21 days of  MgD [150]. Molondialdehyde 
is a genotoxic compound that forms a propano adduct with 
2'-deoxyguanosine rather than an eteno adduct, which can 
produce mutations of  DNA.
The increased formation of  8-OH-dg observed, herein, and 
previously in a variety of  cardiovascular tissues and cells [124-126, 
152], which indicates oxidation of  DNA, supports suggestions 
made years ago, that MgD could lead to multiple mutations in 
the genomes of  multiple cell types [153, 154]. This could help to 
also explain what appears to be, seemingly, paradoxical: i.e., MgD-
induced DNA synthesis with oxidation of  DNA. Alterations in 
the DNA molecules in MgD could mask oxidation of  some DNA 
and, possibly, still yield a synthesis of  DNA as reported here and 
elsewhere [26]. We have demonstrated, previously, that 21 days 
of  short-term MgD in rats resulted in DNA fragmentation and 
lipid peroxidation in intact cardiac and VSM cells [150], whereas 
incubation of  cerebral and peripheral VSM cells (in primary 
culture) resulted in significant synthesis of  DNA after exposure 
to low [Mg2+]0 for a period of  24hr [26]. How can these and the 
present results be reconciled?
Although all cells in the body (except for red blood cells) 
continue to develop strategies to preserve the integrity of  DNA 
structure, numerous factors can alter the structure of  DNA; 
such as reactive oxygen and nitrogen species, numerous extrinsic 
chemical molecules, and UV irradiation to name a few [124-126, 
156]. Each day, DNA of  diverse mammalian tissues and cells 
(including cardiovascular components) receive multiple assaults 
from, for example, guanine methylations, cytosine deaminations, 
spontaneous depurinations, single-strand breaks, double-strand 
breaks, and oxidative lesions, among others [87, 110, 116, 119, 
124, 152, 153, 156, 157]. Every one of  these insults induces 
source-specific damage of  DNA. For example, external chemical 
molecules can cause alkylation of  DNA by methylnitrosourea [152, 
158]. Cancer therapeutic agents such as mitomycin C and cisplatin 
can induce cross-links in DNA [152, 158]. Reactive oxygen and 
nitrogen species can induce very-specific base modifications in 
the DNA [87, 110, 116, 119, 124, 152, 153, 156, 158]. UV light is 
well-known to induce strand breaks in DNA, DNA-DNA cross 
links, and DNA-protein link formations [158]. Interestingly, each 
one of  these assault species cause different DNA aberrations 
leading to different DNA repair processes [152, 153, 156-158]. 
All of  these diverse situations would thus not only alter DNA 
in different ways, affect gene regulation via diverse transcription 
factors, but modulate DNA damage/repair processes. A few 
years ago, using a short-term model of  MgD, we found that 
cardiovascular tissues and cells demonstrated marked reductions 
in glutathione content coupled to activation of  both e-NOS and 
n-NOS [95]. Since eNOS activity has been reported recently to be 
important in activation of  PAF in endothelial cells [114, 116], our 
findings of  low Mg2+ -induced synthesis/generation of  eNOS 
in cardiovascular tissues and cells may trigger (and be linked), 
in part, to activation of  the SM-ceramide pathways [95], DNA 
damage and synthesis.
Interestingly, it has been reported recently that DNA damage 
and the DNA damage response have been identified in human 
atherosclerosis [159, 160]. As we demonstrated approximately 
25 years ago, in a rabbit model, suboptimal dietary intake of  Mg 
(similar to that which 65% of  the North Americans ingest daily) 
results in rapid atherosclerosis with plaques over more than 60% 
of  the aortic and coronary arterial surfaces [21]. Recent human 
studies, using serial angiography coupled with postmortem 
studies, suggest that many plaques appear to invade coronary 
arterial walls months before myocardial infarctions and in the 
absence of  blood clots [161]. Our previous studies indicated 
that low [Mg2+]0 environments lead to coronary vasospasm and 
ischemia prior to plaque formation [3, 25, 29, 53, 120, 151, 162]. 
Depending on the diverse type of  DNA modification, cells would 
exact different repair processes in situ in order to remove such 
damage. In contrast to the in vitro situation, cells in primary culture 
(under tightly controlled environments, such as the present study) 
would be expected to show possibly different effects, e.g., with 
low [Mg2+]0, i.e., DNA synthesis (over short incubation times) as 
shown here and elsewhere [26]. Thus, it is important to keep in 
mind that both DNA damage and synthesis could be expected 
in diverse tissues and cells in vivo, depending upon time and 
circulating/ cellular levels of  free ionized Mg. From this argument, 
when taken together with data presented herein and elsewhere 
[3, 4, 6-9, 15-31, 34, 37-39, 41, 48, 56, 59, 65-67, 74, 76-82, 88-
99, 105-107, 150, 151], low Mg environments could be expected 
to exert multiple effects/actions in atherogenesis, inflammatory 
conditions, on the aging process, and thus on cardiac stability.
Approximately eight-10 years ago, it was shown by Lee et al. in 
HL-60 cells and Xenopus oocytes that a membrane-associated, 
CoA-independent transacetylase can transfer the acetate group 
from PAF to sphingosine and form ceramide [163]. Whether or 
not this enzyme-pathway exists in VSM cells and cardiac muscle 
cells is not known. However, since we have recently demonstrated 
that low [Mg2+]0 can result in formation of  some sphingosine 
and ceramide via the "salvage pathway" [98], we are tempted to 
speculate that the pathway discovered by Lee et al leading to PAF 
and ceramide may be operative and important in the cardiovascular 
effects of  MgD. Almost 20 years ago, we reported, using the same 
VSM cell (herein) and proton-NMR spectroscopy that low Mg2+ 
environments resulted in rapid formation of  PAF, PAF -like lipids 
and plasmalogens [89]. Lee's work suggests that a number of  PAF-
like lipids and plasmalogens could be transacetylated (as above) to 
form a variety of  important lipids that could play major "roles 
in modifying the biological responses of  PAF by generating a 
variety of  its analogs" [110]. These possibilities, obviously, remain 
to be investigated and could be quite important in atherogenesis, 
inflammationm the aging process, and cardiac stability.
Over the past two decades, a considerable amount of  knowledge 
and insight into the regulation of  PAF-Rs has accumulated 
[144-149]. But, despite these efforts, specific regulatory systems 
for the PAF-Rs, in diverse tissues and cells, remains somewhat 
nebulous. It is currently thought that any factor that can affect 
binding of  PAF (and PAF-like lipids) to their membrane-
receptors or to subsequent PAF-dependent-signaling events 
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would be likely candidates as regulators of  specific PAF-Rs 
[111-114, 147-149]. Our present work could be suggestive of  a 
role for Mg2+ in regulation of  PAF-Rs in VSM cell membranes. 
More than 50 years ago, our labs and other workers [5, 49, 50, 
53, 164-166] reported that Mg2+ ions are needed for the binding 
of  certain neurohumoral molecules (e.g., vasopressin, oxytocin, 
catecholamines, angiotensin II) to their receptors on VSM cells 
as well as their contractile actions. Although not shown, we have 
found that [Mg2+]0 also appears to be important in the VSM 
contractile actions of  PAF [unpublished studies]. So, it would 
appear that from the present studies and others [3-5, 8, 14, 15-32, 
34, 35, 38, 40, 48-56, 59, 65, 72-74, 81, 88-100, 105, 108] that Mg2+ 
plays important and diverse, multiple regulatory actions in VSM 
cells. Much more investigation will, however, be required to reveal 
the specific interactions of  PAF, PAF-Rs, and VSM cells.
Obviously, much work (including the present studies) has been 
brought forth to show that PAF is a major mediator of  multiple 
intracellular interactions and pathways. Our work indicates 
that PAF is a regulator of  several downstream, important 
transcriptional pathways in VSM cells, i.e., NF-kB and proto-
oncogenes, and, most likely, sphingolipid-ceramide pathways.
Mechanisms by which PAF and PAF-Rs function in VSM 
cells: roles of  NF-kB, proto-oncogenes, Mg2+, phenotypic 
changes and vascular remodeling
Platelet-activating factor (PAF) is a phospholipid mediator which 
displays multiple biological and pathophysiological attributes, 
running the gamut from inflammation to cell differentiation 
and proliferation. As is well-known, PAF interacts with specific 
membrane PAF-Rs to initiate all cellular responses via specific 
G-protein-coupled receptors. Although these initiated membrane-
receptor phenomena are mostly established for several tissue-cell 
systems [111-114, 144-149], exactly how PAF and PAF-Rs cause 
vascular remodeling in hypertension and atherosclerosis is not 
clear. A little more than 15 years ago, PAF was identified as a 
molecule that stimulated activation of  NF-kB [113, 114, 148].
NF-kB is now known to be a prime regulator of  growth processes, 
differentiation, cell migration, and cell death [for reviews, see ref. 
[83-86]], all factors required for vascular remodeling in hypertension 
and atherogenesis [1, 87]. NF-kB is clearly a major transcription 
factor and a pleiotrophic regulator of  numerous genes involved in 
inflammatory processes and epigenetic phenomena [83-86]. NF-
kB is now thought to be a pivotal transcription molecule involved 
in atherogenesis, hypertension and stroke [1, 15, 26, 29, 81, 87, 
88, 97, 164, 165, 168]. As of  now, it is still not clear as to what 
factor (s) initiates expression of  these molecular events. We were 
the first laboratory to suggest and provide evidence for a role 
for activation of  NF-kB in development of  low [Mg2+]0 -induced 
atherosclerosis [26]. We demonstrated that when VSM cells 
were exposed to low concentrations of  [Mg2+]0, a concentration-
dependent upregulation of  NF-kB took place; the lower the 
[Mg2+]0, the faster and greater the upregulation of  NF-kB [26, 
81, 82]. The present results confirm and extend these findings, as 
do other subsequent studies in endothelial cells [167]. However, 
herein, we demonstrate that lowering extracellular Mg2+ also 
results in a rapid rise in active PAF prior to NF-kB activation. 
Simultaneously and concomitant with the latter we have shown 
that two proto-oncogenes, c-fos and c-jun, are formed, most 
likely as a consequence of  PAF synthesis and concomitant release 
/synthesis of  ceramide. The fact that the specific PAF-R blocker, 
WEB2086, inhibits the PAF-stimulated formation of  the proto-
oncogenes in the VSM cells in our present experiments lends 
considerable support for this contention.
Several lines of  evidence suggest that ceramides are important in 
cytokine generation and in cytokine-induced apoptosis [81, 82, 
140, 167, 168], events which are pivotal in vascular remodeling in 
atherogenesis and hypertension [1, 13]. In this context, we have 
shown both in short-term MgD in intact rats and in vitro, using 
primary cell culture of  VSM cells, exposed to low extracellular 
Mg2+, that these pertubations result in synthesis/release of  at 
least 12 different cytokines and chemokines [81, 82], known to 
be involved in development of  atherosclerosis and hypertension. 
It is important, here, to point out, again, that phenotypic 
transformation of  VSM cells go from a differentiated state to a 
proliferative one during vascular injury and inflammation, early 
events in atherogenesis [1, 13, 109]. Cytokines, in particular, such 
as TNF-alpha, induce VSM migration and proliferation mediated 
by several molecular pathways such as ERK and p38MAPK [155, 
164-166, 168], which we have found to be upregulated in VSM 
cells exposed to low [Mg2+]0 [54, 56]. It is of  considerable interest 
to note, here, that these 12 different cytokines and chemokines 
(which we have shown to be upregulated in MgD) have also been 
reported to be generated in the presence of  PAF [113-115, 146]. 
Moreover, cytokines such as TNF-alpha, stimulate formation 
of  superoxide dismutase, reactive oxygen and nitrogen species, 
and hydrogen peroxide [154], all of  which we have found to be 
upregulated in MgD in cardiovascular cells and tissues [15, 25, 
26, 81, 82, 88, 89, 90, 91, 95, 151] present studies with HNE]. 
We, thus, believe that MgD and its stimulation of  PAF present a 
powerful combination with the generation/release of  ceramide 
for a prime mechanism for vascular remodeling of  arteries and 
arterioles which perforce are a sine-qua-non in atherosclerosis and 
hypertension. The fact that the PAF-R blocker, WEB2086, inhibits 
a great deal of  NF-kB activation, proto-oncogene formation, 
and lipid peroxidation (seen in present work with inhibition of  
4-HNE) in VSM cells, exposed to low [Mg2+]0, lends considerable 
credence to our hypothesis. It is of  considerable interest, here, to 
note that in our rabbit model of  MgD-induced atherosclerosis, 
there were early signs of  histochemical identification of  PAF in 
the lipid - laden arterial VSM cells [unpublished findings].
Over the past 20 years, data has accumulated, from many sources, that 
both c-fos and c-jun proteins (components of  AP-1 transcription 
factor) are critically involved in the mediation of  nuclear events 
provoked by numerous stimuli [83-87, 172-174]. The proto-
oncogenes c-fos and c-jun are known to participate in numerous 
pathophysiological processes including signal transduction, cell 
growth, differentiation, and cell transformation [83-87]. Both 
c-fos and c-jun are thought to play roles as potent inducers of  
apoptosis in several cell types [83-87]. The proto-oncogenes c-fos 
and c-jun encode nuclear phosphoproteins. Members of  the 
c-fos and c-jun families dimerize to preferentially bind AP-1 sites 
with very high affinity. We believe the upregulation of  the proto-
oncogenes, in the present study, by PAF and low [Mg2+]0, as well 
as our previous experiments in vivo and in vitro, support the notion 
that c-fos and c-jun upregulate genes controlling cell growth, 
differentiation, and cell transformation via AP-1 binding genes, 
all of  which are essential in atherogenesis and hypertension. In 
normal VSM and cardiac muscle cells, the expression of  growth 
factors and their receptors is carefully controlled. However, over-
Altura BM et al., (2016) The  Expression of  Platelet-Activating Factor is Induced by Low Extracellular Mg2+ in Aortic, Cerebral and Neonatal Coronary Vascular Smooth Muscle; 
Cross Talk with Ceramide Production, Nf–Kb and Proto-Oncogenes: Possible Links to Atherogenesis and Sudden Cardiac Death in Children and Infants, and Aging; Hypoth- esis, 
Review and Viewpoint. Int J Cardiol Res.. 3(1), 47-67. 60
   OPEN ACCESS                                                                                                                                                                              http://scidoc.org/IJCRR.php
activity of  the c-fos and c-jun proto-oncogenes could result in 
unregulated cell proliferation like that observed in atherogenesis 
and hypertension. Our new findings support the hypothesis we 
advanced previously: "that overexpression of  c-fos and c-jun in 
the cardiovascular system of  MgD animals and humans may play 
an important role in the course of  tissue inflammation and the 
inflammatory response observed in the atherogenesis noted in 
MgD animals" [83-87].
The observations presented, herein, when taken together with 
other studies from our labs [25, 26, 29, 97], indicate that low 
[Mg2+]0 is a powerful stimulant for formation of  both c-fos and 
c-jun proteins in primary cultured VSM cells. In addition, it 
now appears from the present work that PAF, acting via specific 
PAF-Rs on VSM cells, is also a powerful stimulant of  the proto-
oncogenes acting probably via ceramides and NF-kB, and most 
likely PKC activation coupled to Ca2+ entry and intracellular 
release [26].
Magnesium deficiency, PAF and unexplained sudden 
cardiac deaths in infants, children and young adults
Sudden infant death syndrome has become a significant problem 
without an agreed-upon pathological mechanism(s) [for reviews, 
see [128-134]]. Explanations run the gamut from hypoxia, 
gene mutations, cardiac conduction abnormalities, inherited 
channelopathies, unknown infections, diaphragmatic dysfunctions, 
central hypoventilation, susceptibility to ventricular arrhythmias, 
etc [128-134]. Pediatric sudden cardiac arrest likewise seems, for 
the most part, to be growing problem around the world with little 
in the way of  an acceptable pathogenic mechanism(s) [for reviews, 
see [130, 131, 133, 134]]. Sudden cardiac death (SCD) accounts 
for approximately 20% of  nearly all deaths in Western countries 
with multiple possible, but little agreed-upon, explanations. SCD 
in the young (< 35 yrs of  age) has a structural/genetic basis in 
only about 20% of  all cases in the Western world [128-134]. In 
these SCD cases, there is no structural/pathological evidence for 
any heart abnormalities on autopsies [128-134].
Approximately 35 years ago, our laboratories reported that 
mammalian coronary arteries (including from humans) 
demonstrate intense vasospasm as [Mg2+]0 concentrations are 
progressive lowered in in-vitro studies; the lower the reduction in 
[Mg2+]0, and the smaller the coronary vessel, the more intense the 
coronary arterial vasospasm [3]. No vasodilator, including Ca2+ 
channel blockers can alleviate these intense vasospasms [[3-5]; 
unpublished findings]. These contractile actions of  low Mg2+ 
were potentiated in the presence of  neurohumoral and circulating 
vasoconstrictor agents, such as angiotensin II, vasopressin, 
serotonin, norepinephrine, and a variety of  peptides [3-5, 19, 49]
[50]. The present studies not only provides further evidence for 
this concept, but now implicates formation/synthesis of  PAF, 
most likely, in these unique coronary arterial vasospasms. As 
we have shown, previously, that piglet coronary arteries behave 
similarly in low Mg2+ (i.e., intense vasospasm) [120], the present 
findings using primary culture of  piglet coronary arterial vessels 
lead us to conclude that low dietary levels of  Mg in pregnant 
women, infants and children must be taken into consideration as 
a major underlying mechanism for unexplained SCD in infants, 
children and young adults.
It is of  considerable interest to point out here that several studies 
have been published which indicate that infants and children in 
the U.S.A. demonstrate a much higher percentage of  abnormally 
lowered serum total and ionized Mg levels when compared to 
adults 35-60 years of  age [14, 58, 62, 175-178]. Moreover, our 
studies on infants, children and pregnant women have shown 
a high percentage of  abnormally low serum ionized Mg levels 
as well [58, 62][64]179-181]. Taken together, we believe such 
clinical studies, collectively, provide substantial evidence for our 
hypothesis that unexplained SCD in infants and young children, 
possibly, is due, in large measure to abnormally low serum, VSM, 
and cardiac myocyte Mg levels. With respect to the latter, we have 
shown, working with perfused rat hearts, that even short-term 
MgD results in reductions in a variety of  hemodynamic functions, 
i.e., cardiac output, coronary flows, stroke volume, developed 
pressures, and cellular high-energy phosphate levels with 
concomitant cellular Ca2+ overload [107, 162]. We showed more 
than 40 years ago that Mg2+ blocks the entry and release of  Ca2+ 
from both VSM and cardiac myocytes [53, 107]. This together 
with the adverse effects of  low Mg on both hemodynamics and 
energy production (and utilization) would perforce seriously 
compromise young hearts and result in SCD. Whether or not PAF 
plays an intermediate or trigger role in the effects of  MgD on the 
heart's physiological functions remains to be determined.
Low Mg, PAF, telomerase activity, and aging
Aging is clearly agreed to be critical in the etiology of  metabolic 
decline in most human subjects as they near their 65th birthday. 
A great many human subjects at 65 years of  age demonstrate 
clear signs of  metabolic and physiologic functional decline, 
atherosclerosis in most major arteries, high blood pressure, diverse 
cardiovascular diseases, and often type 2 diabetes, which contribute 
in major ways to congestive heart failure by their 75th -85th years. It 
must be pointed out, here, that all of  these aberrations have been 
shown (or to be associated with) both experimentally and clinically, 
with the presence of  MgD when they have been looked for [14-
18, 25, 26, 28, 29, 31-36, 52, 57, 71, 105-107, 150, 151, 167]. It is 
well- known that the aging process is associated with elevations in 
blood/serum/tissue levels of  many of  the same proinflammatory 
cytokines and chemokines found in MgD animals, e.g., IL-1, IL-
2, IL-6, TNF-alpha, among many others [for recent review, see 
chapters in ref. [185]]. Reduced levels of  telomerases are known 
to be associated with elevated levels of  several cytokines (e.g., 
TNF-alpha) in a number of  aged cell types as well as in serum and 
cardiovascular tissues and VSM cells of  MgD animals [ for review, 
see [99] ]; these phenomena being associated with ( and correlated 
to ionized Mg levels, ceramide generation, and activation of  NF-
kB and proto-oncogene pathways) [99]. It should be pointed out, 
here, that normal amounts of  telomerases in all cell types are 
required to promote efficient cell cycle kinetics and normal cell 
growth [100-103]. MgD is well-known to promote disturbances 
in cell cycle kinetics [186-188] via reactive oxygen and nitrogen 
species [15, 25, 26, 29, 33, 67, 88, 91, 95, 98, 99, 106, 151], most 
likely acting to downregulate telomerases [99, 100-103].
Recently, we showed, in animals subjected to 21 days of  MgD, 
that telomerase levels are downregulated coupled to oxidation of  
DNA and increased levels of  p53 [99]. Such data supports the 
idea that MgD could lead to multiple mutations in the genomes 
of  multiple cell types. Our previous studies, when viewed in light 
of  the present experiments, would support the hypothesis that 
mutations and transformations of  VSM, endothelial, and cardiac 
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myocte cells caused by ceramides, MgD and oxidation of  DNA 
(seen in atherogenesis, hypertension, stroke, and congestive heart 
failure) may play major roles in the aging process, thus leading 
to multiple cardiovascular changes including inflammations of  
the vascular walls, high blood pressure (due to formed elemental 
changes, release of  ceramides, release of  cytokines, excess lipid 
wall deposition, lipid peroxidation, etc.), cardiac dysfunctions, and 
eventual cardiac failure and/or strokes.
Almost 30 years ago, two of  us reported, for the first time, the 
importance of  the endothelial lining of  blood vessels in the 
responses of  arterial muscles to reduced levels of  [Mg2+]0 [180]. 
More recently this work has been expanded by our laboratory 
and others [167-181], reinforcing the roles of  Mg in control of  
the microcirculation, blood pressure, distribution of  blood flow, 
inflammation and herogenesis [4, 14, 15, 17, 18, 19, 20, 25, 29, 34, 
49, 53, 59, 68, 74, 77, 78, 79]. We have found, as stated above, that 
short-term MgD causes marked reductions in the cardiovascular 
tissue/cell levels of  the free radical scavenger glutathione (which 
is correlated with reduced Mg levels) coupled to fragmentation 
of  DNA (and oxidation) and activation of  diverse nitric oxide 
synthases [15, 25, 81, 82, 89, 90, 91, 93-95, 97-99, 150]. Such data, 
when viewed in light of  the present work, with PAF, supports the 
hypothesis that MgD would be expected to cause mutations in 
many types of  cells. These aberrations would promote accelerated 
aging processes in many bodily tissues and cells. In addition, 
such alterations in cell types and recruitment of  a multiplicity 
of  diverse white blood cells are the hallmarks of  atherogenesis, 
and inflammatory responses needed to initiate and sustain the 
atherosclerotic process.
The microcirculation, white blood cells, inflammation, 
atherogenesis, MgD, PAF and ceramide
Approximately 40 years ago, Dr. Russell Ross and colleagues 
advanced the hypothesis that atherosclerosis is an inflammatory 
disease brought about by injury to the endothelial surfaces of  
blood vessels in the macro-and micro-circulations [see ref  [109], 
for summary of  their hypothesis]. The hypothesis stated that 
different forms of  injury will result in numerous dysfunctions 
in the homeostatic properties of  the endothelium, e.g., increase 
in adhesiveness of  leukocytes and/or platelets, alteration in 
the procoagulant properties, formation/release of  cytokines/
chemokines and growth factors. Usually, inflammation is defined 
as a response of  microcirculatory blood vessels and the tissues 
they perfuse to infections and damaged tissues which bring cells 
and host-defense molecules directly from the circulation to all the 
diverse sites where they are required, in order to eliminate/degrade 
the offending agents [for reviews, see [223, 224], for reviews]. The 
mediators of  the defense mechanisms include white blood cells, 
phagocytic leukocytes, antibodies, chemokines and complement 
proteins [13, 223-226]. Most of  these cells and molecules are 
recruited,when needed, from the circulating blood itself. The 
inflammatory process brings these cells and molecules to the 
damaged or necrotic tissues. The absence of  the inflammatory 
process would allow infections to continue unchecked, prevent 
wounds from healing, and result in festering sores/wounds. A 
typical inflammatory response develops in a sequential manner: 
recognition of  the offending agent(s) by host cells and molecules; 
recruitment of  leukocytes and plasma proteins; activation of  
the leukocytes and plasma proteins to destroy and eliminate all 
offending substances; control and termination of  the reaction(s); 
and finally repair of  the damaged tissue(s). During the normal 
inflammatory process, leukocytes migrate across the venous 
capillary walls through the endotheliun due to increases in 
permeability and move to the site(s) of  injury via chemotaxis. The 
normal mediators for these processes to take place are: adhesion 
molecules; and cytokines and chemokines. Interestingly, all of  
these mediators are needed for atherogenesis and are released/
formed in MgD [14, 15, 23-27, 29, 34, 38, 41, 81, 82, 88-91, 95, 
97, 99, 167, 226]. If, however, the inflammatory response is not 
curtailed, or effectively neutralized, the inflammatory response 
will go-on and stimulate migration and proliferation of  VSM cells 
which will become intermixed with the inflammatory cells and 
protein components to initiate and form an intermediate lesion 
(i.e., beginning of  the atherosclerotic process). If  these processes 
go-on unabated, the arterial walls will thicken and initially dilate 
to compensate, to a point, then undergo a remodeling process in 
which the normal contractile VSM cells are transformed into a 
new non-contractile phenotype [109, 223, 224]. At every stage of  
this process macrophages, monocytes, and T-lymphocytes will be 
attracted and adhere to the arterial-endothelial walls [109, 223, 224. 
Activation of  these cells results in release of  hydrolytic enzymes, 
cytokines, chemokines, and growth factors, as stated above. 
These factors will sustain and perpetuate the atherogenic process 
forming, eventually, fibrous tissue and further enlargement of  
the lesion, which will overlie a core of  lipid resulting in plaques 
and necrotic tissue. MgD, itself, results in release of  hydrolytic 
enzymes, cytokines, chemokines, and growth factors involved 
in the early stages of  the atherogenic process demonstrating 
lesions and plaques on the inner endothelial surfaces [23, 25, 38, 
74, 81, 98, 167]. In developing atherosclerosis, each plaque has a 
cap that retains cholesterol, and inflammation inside the plaques 
can dissolve the fibers, but, suddenly, the cap ruptures, spilling 
cholesterol into the insides of  the arteries which can promptly 
cause clots that can completely block the flow of  blood into the 
microcirculation of  the surrounding tissues. It has been shown by 
our lab [81,93,94,unpublished findings ] and others that ceramides, 
in increased levels, are found in the atherogenic process (i.e, mixed 
in the plaques), at least in rabbits [227, 228], and most importantly, 
are stimulated in MgD [25, 81, 93. 94] unpublished findings ].
Using open-and closed window chambers [see ref  [229-232] for 
methods] implanted in the cerebral cortex, of  living rats and mice 
in situ, on MgD diets for 21 days [A. Gebrewold, A. Carella, B.T. 
Altura & B.M. Altura, unpublished findings ], as well as in the skin 
and skeletal muscles of  MgD rats and mice, we found increased 
numbers of  white blood cells (including monocytes, phagocytic 
leukocytes, and lymphocytes) on the endothelial surfaces of  
microcirculatory blood vessels using intravital microscopy at high 
magnifications (e.g., up to 4,000x normal). We have shown recently 
that after 12-18 weeks on MgD diets, which produces increases 
in arterial blood pressure [17, 18], these microvasculatures 
demonstrate less rolling of  the white blood cells and much more 
adherence of  the white blood cells to the endothelial surfaces [A. 
Gebrewold & B.M. Altura, unpublished findings]. Does PAF play 
any role in these inflammatory events?
PAF is known to play major roles in both inflammatory responses 
and atherogenesis [111-115]. A variety of  the circulating blood 
cells (e.g., leukocytes, platelets, basophils, macrophages, and 
endothelial cells) can elaborate PAF [113-115], including the 
VSM cells shown herein. In addition, like MgD, PAF produces 
vasoconstriction of  blood vessels and VSM [111, 113-115], as do 
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several of  the ceramides [15, 92, 137, 233, 234]. A number of  
investigators employing intravital microcirculatory techniques, 
similar to those used by our group, have clearly demonstrated that 
PAF increased the numbers of  white blood cells in the microvessels 
concomitant with intense vasoconstriction-spasms with increasing 
dosing of  the lipid mediator, less rolling, and increased adherence 
of  the leukocytes to the endothelial surfaces with increases in 
vascular permeabilty [235-240]. Using open and closed chambers 
implanted in rodent cerebral cortex and skeletal muscle, we have 
observed similar phenomena [A. Gebrewold, B.T. Altura & B.M. 
Altura, unpublished findings]. In addition, we have reported that 
a variety of  ceramides produce similar microcirculatory actions 
in rodent cerebral, cutaneous and skeletal muscle circulatory 
systems, including increased permeability of  the postcapillary 
venular walls, major sites of  inflammatory reactions [[234]; A. 
Gebrewold et al, unpublished findings]. Collectively, these in 
vivo microcirculatory findings strongly support the hypothesis 
that both PAF and ceramides induce similar, true inflammatory 
responses in diverse vascular beds in diverse mammalian species.
Having the above, large number of  in vivo microcirculatory studies, 
from our labs and others, we hypothesize that since MgD results in 
most of  the attributes of  early atherogenesis, including synthesis/
release of  PAF and ceramides, PAF and ceramides mostly likely 
are important, if  not critical, mediators released/synthesized in 
cardiovascular tissues to initiate the early atherosclerotic process.
MgD, PAF, N-SMases, acid-SMAses, ceramide, and Ca2+
When the current work is viewed in light of  an accumulation of  
other pertinent data, published elsewhere [15, 25, 26, 81, 82, 89-91, 
93-95, 97-99, 150], we conclude that upregulation of  N- and acid 
SMases (probably in large measure by PAF formation and Ca2+ 
entry/intracellular release), which are induced in all cardiovascular 
tissues and cells, in at least three different mammalian species [see 
above refs.; present studies], in short-term MgD, results in the 
formation/release of  ceramides and multiple signal transduction 
pathways; eg., activation of  PKCs, activation of  MAP kinases, 
activation of  NF-kB, activation of  proto-oncogenes, activation 
of  p53, activation of  AP-1, release of  cytokines/chemokines, 
as well as other cell signals. As reviewed above, and elsewhere 
[5, 15, 19, 25, 27, 29, 30, 34, 49-51, 53, 72, 73, 107, 120, 189-
191], Mg2+ plays pivotal roles in control of  cellular Ca2+ uptake, 
subcellular content, and subcellular distribution in smooth muscle 
cells, endothelial cells, and cardiac muscle cells [5, 19, 26, 30, 49, 
50, 53, 72, 92, 107, 120, 162, 190, 191]. Mg2+ regulates cardiac 
hemodynamics, regulation of  the microcirculation, vascular 
tone, vascular reactivity, endothelial functions, clotting of  blood 
formed elements, carbohydrate, nucleotide, and lipid metabolism, 
prevention of  free radical formation, and stabilization of  the 
genome [4, 11, 14, 23, 25, 37, 49, 59, 74, 75, 79, 81, 82, 88-99, 
105-107, 150, 151, 162, 167].
With the advent of  new Mg2+ - ion selective electrodes, a new era 
has been ushered -in for the diagnosis and potential treatment 
of  hypertension, ischemic heart disease, atherogenesis, peripheral 
vascular diseases, preeclamptic- eclamptic disorders in pregnant 
women, diabetic-related vascular diseases, sickle cell anemic-
related vascular diseases, trauma-shock injuries, cardiac failure, 
strokes, and organ transplantation [15, 17, 25, 27, 31, 35, 57, 
58, 60, 70, 89, 91, 192-208]. Since most of  these disorders (or 
clinical situations) become worsened with age, or take place in 
the natural aging process, and are known (from mostly our 
studies) to be associated with varying degrees of  MgD, the role 
of  Mg in carbohydrate, lipid, nucleotide, RNA, DNA, and protein 
metabolism, and the effects of  Mg deficiency, particularly on 
sphingolipid metabolism, appear to play vital roles on telomerase 
activities and telomerases, and, most likely, the genome.
Magnesium deficiency and genotoxicity
In 2010, we first suggested that MgD, by itself, probably 
acts as a genotoxic agent [93, 94]. One of  ceramide's major 
pathophysiological actions is its ability to induce cell differentiation 
and cell transformation [136-141]. Such actions in MgD could 
aid in explaining, to a large extent, transformation of  contractile 
VSM cells to a new phenotype in atherogenesis--i.e., VSM cells 
that no longer contract or relax, but become synthetic machines 
for a variety of  cytokines, chemokines, and growth factors. 
Abnormal cell differentiation, transformation, and growth are 
pivotal events in the development of  atherogenesis, hypertension, 
and progressive cardiac failure. Hyperplasia and cardiovascular 
hypertrophy are common events in aging, hypertension, and 
progressive cardiac failure [1, 2, 185]. But, the precise mechanisms 
are not completely understood.
PAF, ceramide, and the tumor suppressor factor p53 are now 
known to play key roles in cell transformations, growth, apoptotic 
events, and the aging process [83-87, 110, 115, 135-141, 145, 147-
149, 209, 210]. PAF, ceramides and p53 all can induce cell cycle 
arrest (and senescence), induce programmed cell death, and are 
associated with DNA damage ( i.e., genotoxic events) [83-87, 110, 
115, 135-141, 145, 147-149, 209, 210]. As reviewed above, and 
elsewhere [15, 16, 26, 29, 74, 91, 99, 107, 151], MgD can produce 
all of  these events in multiple cell types, including cardiac and 
VSM cells. Over the past 12 years [15, 25, 81, 82, 89-91, 93-95, 97, 
99, 211-218] (including studies herein), we have shown that MgD 
(via activation of  p53 [94] and now PAF) is a "driver" of  ceramide 
synthesis/release via multiple cellular pathways in diverse cardiac 
and VSM cells, including, now, neonatal coronary VSM cells.
It should be recalled, here, that atherosclerotic plaques in the 
vascular walls of  hypertensive human subjects demonstrate 
considerable DNA damage, activation of  DNA repair pathways, 
increased expression of  p53, increased expression of  proto-
oncogenes, activation of  NF-kB, oxidation, lipid peroxidation, 
and apoptosis [110, 157-160]. We have found all of  these 
pathobiological alterations in MgD experimental animals. We do 
not believe this is a coincidence. Experimentally, MgD results 
in accelerated atherosclerotic plaques in rabbit and mice arterial 
walls [21, 22, 24], which has been associated with increased levels 
of  p53 [94] and PAF [110, 115] in the thickened atherosclerotic 
plaques and decreased levels of  telomerases [unpublished 
findings]. We, thus, hypothesize that MgD plays key roles in the 
generation of  atherosclerotic plaques, coronary arterial diseases, 
and hypertension via the upregulation of  N-SMases, acid-
SMases, p53, ceramide synthase, PAF generation, and ceramide 
production as well as downregulation of  telomerases, particularly 
as the majority of  individuals who consume Western-type diets 
have 45-70% short falls in daily Mg intake. All of  the foregoing 
events could be expected to be accelerated in the aging population, 
particularly in old-age and nursing homes where the daily intake 
of  Mg often approaches deficits near 80-90% [14, 67].
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Low Mg intake and epigenetic processes
Various modifications take place daily and over various periods 
of  time via epigenetics [220, 221]. Epigenetic modifications are 
chromatin-based modifications that alter expression of  genes 
without altering the DNA sequence itself  [220-223]. The most 
common epigenetic modifications include methylation of  DNA, 
posttranslational modification of  histone proteins, and RNA-
based mechanisms [222, 223]. These biochemical and molecular 
events can modulate the tertiary structure and, therefore, the 
accessibility of  promoter DNAs or encoding transcription factors 
and numerous regulatory molecules that, in the end, finally alter 
transcription [220-223]. In these ways, epigenetic pathways 
are pivotal in the regulation of  VSM, endothelial, and cardiac 
myocyte gene expressions. Alterations in gene expression, for 
example, would change a normal contractile VSM cell into a cell 
that becomes a synthetic machine for numerous factors needed 
for atherogenesis, i.e., cytokines, chemokines, growth factors, etc.; 
the VSM cell would no longer be a contractile functioning cell 
type under such transformative conditions. We believe prolonged 
MgD does this and more.
Bioavailable Mg intake and prevention of  cardiovascular 
diseases
Last, but not least, our results bolster the idea, we have espoused 
previously, that water intake (e.g., from tap waters, well waters, 
bottled waters, beverages using tap/well/spring waters, or 
desalinated waters) in humans should contain at least 25-40 
mg Mg2+/l [81, 82, 91, 93-95, 97-99, 150]. The latter inclusion 
in our diets should go a long- way towards the prevention of  
cardiovascular diseases and ameliorate the aging process of  bodily 
tissues and cells in humans worldwide. In 2009, The World Health 
Organization recommended our guidelines of  25-40 mg Mg2+/l 
to be included in drinking waters for human consumption [241].
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